Completed OBSERVATIONAL NCT00949286

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study (ADVANCE-ON)

Sponsor: Servier

Updated 7 times since 2017 Last updated: May 15, 2014 Started: Jan 31, 2010 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00949286, this observational or N/A phase trial focuses on Diabetes Mellitus, Type 2 and remains completed. Sponsored by Servier, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Servier
The George Institute

Data source: The George Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aberdeen, United Kingdom , Airdrie, United Kingdom , Angers, France , Auckland, New Zealand , Avignon, France , Balatonfüred, Hungary , Ballinasloe, Ireland , Baotou, China , Bath, United Kingdom , Beijing, China and 127 more locations